Peritoneal cells at admission: Do they have prognostic significance in peritonitis

Renal Failure

Volumn 32, Issue 3, 2010, Pages 335-342

  Elsurer, Rengin ^a   Afsar, Baris ^a   Sezer, Siren ^a   Ozdemir, F Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Hospital admission; Lymphomononuclear cell; Neutrophil; Peritoneal dialysis; Peritonitis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BACTERIAL PERITONITIS; CONTROLLED STUDY; DIALYSATE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL COUNT; PERITONEAL DIALYSIS; PERITONEUM CELL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT INFECTION;

ADULT; ASCITIC FLUID; C-REACTIVE PROTEIN; DIALYSIS SOLUTIONS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; NEUTROPHILS; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS;

EID: 77950592833     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860221003611679     Document Type: Article

References (25)

1. Kent JR, Almond MK. A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): Support for the ISPD guidelines. International Society for Peritoneal Dialysis. Perit Dial Int. 2000;20:301-305.
2. Hurst SM, Wilkinson TS, McLoughlin RM, et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14:705-714.
3. Enriquez J, Klinger J, Arturo JA, Delgado M, Tobar C, Mosquera M. Peritonitis in continuous ambulatory peritoneal dialysis: Cytokines in peritoneal fluid and blood. Adv Perit Dial. 2002;18:177-183.
4. Shetty H, Gokal R. Treatment of infections in peritoneal dialysis. Contrib Nephrol. 2003;140:187-194.
5. Diaz-Buxo JA. What is the role of automated peritoneal dialysis and continuous flow peritoneal dialysis? Contrib Nephrol. 2003;140:264-271.
6. McLoughlin R. Resolving peritoneal inflammation: Flicking the right "switches". Perit Dial Int. 2005;25:223-229.
7. Henderson RB, Hobbs JA, Mathies M, Hogg N. Rapid recruitment of inflammatory monocytes is independent of neutrophil migration. Blood. 2003;102:328-335.
8. Tzamaloukas AH. What affects the outcome of peritoneal dialysis? Going beyond the microbial etiology. Perit Dial Int. 2002;22:563-565.
9. Glik A, Douvdevani A. T lymphocytes: The "cellular" arm of acquired immunity in the peritoneum. Perit Dial Int. 2006;26:438-448.
10. Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. The Ad Hoc Advisory Committee on Peritonitis Management. Perit Dial Int. 1989;9:247-256.
11. Troidle L, Finkelstein F. Treatment and outcome of CPDassociated peritonitis. Ann Clin Microbiol Antimicrob. 2006;5:6.
12. Piraino B, Bailie GR, Bernardini J, et al. ISPD Ad Hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107-131. (Pubitemid 40484720)
13. Glik A, Mazar J, Rogachev B, Zlotnik M, Douvdevani A. CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment. Perit Dial Int. 2005;25: 240-247. (Pubitemid 40724204)
14. Zelenitsky S, Barns L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000;36:1009-1013.
15. Korbet SM, Vonesh EF, Firanek CA. Peritonitis in an urban peritoneal dialysis program: An analysis of infecting pathogens. Am J Kidney Dis. 1995;26:47-53.
16. Bernardini J, Holley JL, Johnston JR, Perlmutter JA, Piraino B. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1991;36:29-34.
17. Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002;22:573-581.
18. Kim GC, Korbet SM. Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis. 2000;36:1000-1008.
19. Bunke M, Brier ME, Golper TA. Culture-negative CAPD peritonitis: The Network 9 Study. Adv Perit Dial. 1994;10: 174-178.
20. Troidle L, Majahan A, Gorban-Breannan N, Kliger AS, Finkelstein FO. C-reactive protein, peritonitis and outcome. Perit Dial Int. 2001;21(Suppl. 1):S45.
21. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: A review and current concepts. Semin Dial. 2003;16:428-437.
22. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25:274-284.
23. Cueto-Manzano AM, Quintana-Pina E, Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int. 2001;21:148-153.
24. Szeto CC. Peritonitis-cells, cytokines, and local defense. Hong Kong J Nephrol. 2002;4:63-64.
25. Martikainen TA, Ekstrand AV, Honkanen EO, Teppo AM, Gronhagen-Riska C. Dialysate leukocytes, sICAM-1, hyaluronan and IL-6: Predictors of outcome of peritonitis? Blood Purif. 2004;22:360-366.